{"organizations": [], "uuid": "95f59d8ab102b926e8671edb64401a248b21aa2a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s1.reutersmedia.net/resources/r/?m=02&d=20180208&t=2&i=1229416028&w=1200&r=LYNXMPEE17171", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/us-cvs-results-antitrust/cvs-says-aetna-acquisition-still-expected-in-2018-idUSKBN1FS27S", "country": "US", "domain_rank": 408, "title": "CVS says Aetna acquisition still expected in 2018", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-08T16:13:00.000+02:00", "replies_count": 0, "uuid": "95f59d8ab102b926e8671edb64401a248b21aa2a"}, "author": "", "url": "https://www.reuters.com/article/us-cvs-results-antitrust/cvs-says-aetna-acquisition-still-expected-in-2018-idUSKBN1FS27S", "ord_in_thread": 0, "title": "CVS says Aetna acquisition still expected in 2018", "locations": [], "entities": {"persons": [{"name": "chizu nomiyama", "sentiment": "none"}, {"name": "caroline humerediting", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "new york", "sentiment": "none"}], "organizations": [{"name": "cvs", "sentiment": "negative"}, {"name": "aetna", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "aetna inc", "sentiment": "none"}, {"name": "u.s. department of justice", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "cvs health corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEW YORK (Reuters) - CVS Health Corp ( CVS.N ) on Thursday said that a request for more information from U.S. antitrust regulators reviewing its proposed $69 billion acquisition of health insurer Aetna Inc ( AET.N ) does not impact its expectation that the deal will close in the second half of 2018.\nThe companies said on Feb. 1 that they had been contacted by the U.S. Department of Justice for additional information. The companies have a shareholder meeting scheduled for March 20 to vote on the transaction.\nReporting by Caroline HumerEditing by Chizu Nomiyama\n ", "external_links": [], "published": "2018-02-08T16:13:00.000+02:00", "crawled": "2018-02-08T16:33:07.011+02:00", "highlightTitle": ""}